DiaSorin Inc.

Increased antimicrobial resistance is one of the key healthcare challenges around the world. The misdiagnosis of disease etiology is due to the difficulty in quickly identifying whether an infection is viral, bacterial, or co-infection, resulting in the misuse of antibiotics. This not only alters the trajectory of patient care but can also lead to additional costs for hospital admissions and length of stay. Based on computational integration of the levels of three host immune system biomarkers the LIAISON® MeMed BV® assay helps in distinguishing bacterial from viral etiologies in pediatric and adult patients with lower respiratory tract infection or clinical presentation of fever without source, guiding downstream clinical management while also fighting the problem of antimicrobial resistance. Three biomarkers + machine learning = better patient care. Visit us at the DiaSorin booth (#2701) to learn more.

Simplexa^® Congenital CMV Direct is a qualitative, in-vitro, real-time PCR assay designed to streamline your workflow. Offering urine- or saliva-based sample testing, our ready-to-use PCR reagent mix is conveniently added onto a re-usable Direct Amplification Disc that is made for use on the intuitive, compact LIAISON^® MDX system. Simply scan samples and reagents, load them directly onto the Direct Amplification Disc, load the disc into the LIAISON^® MDX instrument, and enjoy reliable results supported by integrated QC-run checks with LIS reporting. Additionally equipped with viewable PCR curves and QC Charts as well as in-run software access, experience sample-to-answer reporting, operational simplicity and flexibility, best-in-class clinical utility, and dependable CMV reporting in only 60 minutes.